Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q2)Sep 30, 2025 | (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q4)Mar 31, 2025 | (Q3)Dec 31, 2024 | (Q2)Sep 30, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 2.82%82.67M | 0.85%79.79M | -2.92%331.67M | 12.57%92.82M | -9.25%79.33M | -8.44%80.41M | -5.78%79.12M | 5.57%341.66M | -0.23%82.46M | 7.16%87.41M |
| Cost of revenue | -8.25%35.01M | -3.33%31.76M | 2.03%121.16M | 1.74%32.53M | -12.81%30.87M | 21.12%38.16M | 2.46%32.86M | 9.93%118.75M | 45.03%31.97M | 9.90%35.4M |
| Gross profit | 12.81%47.66M | 3.81%48.02M | -5.56%210.51M | 19.43%60.29M | -6.82%48.46M | -24.98%42.25M | -10.87%46.26M | 3.38%222.91M | -16.69%50.48M | 5.37%52.01M |
| Operating expense | -9.54%6.68M | 43.44%12.63M | 19.59%55.04M | 43.39%16.28M | 2.47%9.5M | -4.94%7.39M | 56.33%8.8M | 11.09%46.02M | -37.69%11.36M | 44.94%9.27M |
| Staff costs | ---- | ---- | 8.94%13.06M | ---- | ---- | ---- | ---- | 30.90%11.99M | ---- | ---- |
| Depreciation and amortization | 39.34%1.43M | 23.77%1.31M | 17.65%4.47M | 22.30%1.27M | 18.09%1.12M | 13.98%1.03M | 15.54%1.06M | 6.16%3.8M | 13.32%1.04M | 2.81%951K |
| -Depreciation | -12.07%903K | -2.65%1.03M | 7.48%4.09M | -4.63%988K | 6.73%1.02M | 13.98%1.03M | 15.54%1.06M | 6.16%3.8M | 13.32%1.04M | 2.81%951K |
| -Amortization | --528K | --279K | --386.72K | --279K | --108K | --0 | --0 | --0 | --0 | --0 |
| Other operating expenses | -17.43%5.25M | 46.12%11.32M | 24.06%37.5M | 45.50%15.02M | 0.68%8.38M | -7.42%6.36M | 64.24%7.75M | 5.38%30.23M | 26.59%10.32M | 52.06%8.32M |
| Operating profit | 17.55%40.98M | -5.50%35.4M | -12.10%155.47M | 12.48%44.01M | -8.84%38.95M | -28.19%34.86M | -19.05%37.46M | 1.55%176.88M | -7.66%39.13M | -0.52%42.73M |
| Net non-operating interest income (expenses) | 6.96%-191.96K | -10.55%-206.32K | ||||||||
| Non-operating interest expense | ---- | ---- | -6.96%191.96K | ---- | ---- | ---- | ---- | 10.55%206.32K | ---- | ---- |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | -18.99M | -18.99M | 0 | 0 | ||||||
| Less:Write off | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| Less:Negative goodwill immediately recognized | ---- | ---- | --18.99M | --18.99M | ---- | ---- | ---- | --0 | --0 | ---- |
| Other non-operating income (expenses) | -86.59%418K | -96.45%106K | 25.28%10.24M | 36,833.33%2.22M | -38.24%1.92M | 32.98%3.12M | 9.93%2.99M | -17.85%8.17M | -99.86%6K | 0.19%3.1M |
| Income before tax | 9.00%41.4M | -12.22%35.5M | -20.73%146.53M | -30.40%27.24M | -10.83%40.87M | -25.37%37.98M | -17.44%40.45M | 0.49%184.85M | -15.73%39.13M | -0.47%45.84M |
| Income tax | 19.07%12.09M | -6.01%9.51M | -11.07%40.99M | 5.30%10.61M | -10.26%10.12M | -19.70%10.15M | -16.44%10.12M | 2.08%46.1M | -13.16%10.07M | 3.63%11.27M |
| Net income | 5.33%29.31M | -14.30%25.99M | -23.94%105.54M | -42.77%16.63M | -11.02%30.76M | -27.25%27.83M | -17.77%30.32M | -0.02%138.75M | -16.58%29.06M | -1.74%34.56M |
| Net income continuous operations | 5.33%29.31M | -14.30%25.99M | -23.94%105.54M | -42.77%16.63M | -11.02%30.76M | -27.25%27.83M | -17.77%30.32M | -0.02%138.75M | -16.58%29.06M | -1.74%34.56M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 5.33%29.31M | -14.30%25.99M | -23.94%105.54M | -42.77%16.63M | -11.02%30.76M | -27.25%27.83M | -17.77%30.32M | -0.02%138.75M | -16.58%29.06M | -1.74%34.56M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 5.33%29.31M | -14.30%25.99M | -23.94%105.54M | -42.77%16.63M | -11.02%30.76M | -27.25%27.83M | -17.77%30.32M | -0.02%138.75M | -16.58%29.06M | -1.74%34.56M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 5.26%0.02 | -14.49%0.0177 | -23.97%0.072 | -42.93%0.0113 | -11.02%0.021 | -27.20%0.019 | -17.69%0.0207 | -0.05%0.0947 | -16.81%0.0198 | -1.67%0.0236 |
| Diluted earnings per share | 5.29%0.0199 | -14.08%0.0177 | -23.99%0.0716 | -42.93%0.0113 | -11.06%0.0209 | -27.59%0.0189 | -17.93%0.0206 | -0.05%0.0942 | -16.46%0.0198 | -1.26%0.0235 |
| Dividend per share | 0 | 0.00%0.035 | -13.33%0.065 | 0 | -25.00%0.03 | 0 | 0.00%0.035 | 66.67%0.075 | 0 | 60.00%0.04 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.